Questcor Pharmaceuticals (NASDAQ:QCOR), a company whose shares are moving quickly, is trading 2.0% higher to $26.64. The S&P is currently trading 0.3% lower to 1,462 and the Dow Jones Industrial Average is trading 0.3% lower to 13,394.
Questcor Pharmaceuticals (NASDAQ:QCOR) has potential upside of 57.1% based on a current price of $26.64 and analysts' consensus price target of $41.86. The stock should run into initial resistance at its 50-day moving average (MA) of $26.65 and subsequent resistance at its 200-day MA of $36.66.
Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
Questcor Pharmaceuticals share prices have moved between a 52-week high of $58.91 and a 52-week low of $14.52 and are now trading 83% above that low price at $26.64 per share. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 0.3%.